Invitrogen™ BCL7A Polyclonal Antibody

Goat Polyclonal Antibody

Supplier:  Invitrogen™ PA517933

Catalog No. PIPA517933

Description

This antibody is predicted to react with bovine, canine, mouse, porcine and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 4,000.

This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.

Specifications

• Antigen: BCL7A
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: BCL7A
• Gene Alias: 4432415N06Rik; AI448316; B cell CLL/lymphoma 7A; B-cell CLL/lymphoma 7 protein family member A; B-cell CLL/lymphoma 7A; B-cell CLL/lymphoma-7; BCL 7; BCL tumor suppressor 7A; BCL7; Bcl7a; LOC690085; similar to B-cell CLL/lymphoma 7A
• Host Species: Goat
• Purification Method: Ammonium Sulfate Precipitation
• Regulatory Status: RUO
• Gene ID (Entrez): 605
• Content And Storage: -20°C, Avoid Freeze/Thaw Cycles
• Form: Liquid

• Applications: Flow Cytometry, Western Blot, Immunocytochemistry
• Concentration: 0.5 mg/mL
• Formulation: TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3
• Gene Accession No.: Q4VC05
• Gene Symbols: BCL7A
• Immunogen: Synthetic peptide sequence (MKLEASQQNSEEM) corresponding to the C-terminus amino acids of BCL7A (aa 198-210).
• Quantity: 100 μg
• Primary or Secondary: Primary
• Target Species: Human
• Product Type: Antibody
• Isotype: IgG